284 related articles for article (PubMed ID: 17108883)
21. Treatment strategies for uterine leiomyoma: the role of hormonal modulation.
Cook JD; Walker CL
Semin Reprod Med; 2004 May; 22(2):105-11. PubMed ID: 15164305
[TBL] [Abstract][Full Text] [Related]
22. Obesity and GnRH action. Report of a case with contribution by peripherally derived estrogens.
Hansen LM; Batzer FR; Corson SL; Bello S
J Reprod Med; 1997 Apr; 42(4):247-50. PubMed ID: 9131500
[TBL] [Abstract][Full Text] [Related]
23. Treatment of perimenopausal women with uterine myoma: successful use of a depot GnRH agonist leading to a natural menopause.
Imai A; Sugiyama M; Furui T; Tamaya T
J Obstet Gynaecol; 2003 Sep; 23(5):518-20. PubMed ID: 12963511
[TBL] [Abstract][Full Text] [Related]
24. [Usefulness of GnRH agonists in preoperative treatment of complicated uterine myomata].
Campusano C; Zapata R; Bianchi M; Badia JI; Arteaga E
Rev Chil Obstet Ginecol; 1993; 58(2):150-4. PubMed ID: 8209044
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of LGD1069 (Targretin), a retinoid X receptor-selective ligand, for treatment of uterine leiomyoma.
Gamage SD; Bischoff ED; Burroughs KD; Lamph WW; Gottardis MM; Walker CL; Fuchs-Young R
J Pharmacol Exp Ther; 2000 Nov; 295(2):677-81. PubMed ID: 11046105
[TBL] [Abstract][Full Text] [Related]
26. Preoperative use of GnRH agonist for leiomyomas.
Hutchins FL
J Reprod Med; 1997 Apr; 42(4):253. PubMed ID: 9131502
[No Abstract] [Full Text] [Related]
27. Leiomyoma pseudocapsule after pre-surgical treatment with gonadotropin-releasing hormone agonists: relationship between clinical features and immunohistochemical changes.
De Falco M; Staibano S; Mascolo M; Mignogna C; Improda L; Ciociola F; Carbone IF; Di Lieto A
Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):44-7. PubMed ID: 19297072
[TBL] [Abstract][Full Text] [Related]
28. Gonadotropin-releasing hormone agonist pretreatment did not decrease postoperative adhesion formation after abdominal myomectomy in a randomized control trial.
Coddington CC; Grow DR; Ahmed MS; Toner JP; Cook E; Diamond MP
Fertil Steril; 2009 May; 91(5):1909-13. PubMed ID: 18439584
[TBL] [Abstract][Full Text] [Related]
29. Elevated level of plasma vascular endothelial growth factor after gonadotropin-releasing hormone agonist treatment for leiomyomata.
Takeda T; Osuga K; Miyake A; Wakabayashi A; Morishige K; Kimura T
Gynecol Endocrinol; 2008 Dec; 24(12):724-6. PubMed ID: 19172544
[TBL] [Abstract][Full Text] [Related]
30. Magnetic resonance guided focused ultrasound surgery of uterine fibroids--the tissue effects of GnRH agonist pre-treatment.
Smart OC; Hindley JT; Regan L; Gedroyc WM
Eur J Radiol; 2006 Aug; 59(2):163-7. PubMed ID: 16740371
[TBL] [Abstract][Full Text] [Related]
31. Preoperative administration of GnRH-a plus tibolone to premenopausal women with uterine fibroids: evaluation of the clinical response, the immunohistochemical expression of PDGF, bFGF and VEGF and the vascular pattern.
Di Lieto A; De Falco M; Mansueto G; De Rosa G; Pollio F; Staibano S
Steroids; 2005 Feb; 70(2):95-102. PubMed ID: 15631865
[TBL] [Abstract][Full Text] [Related]
32. [Gonadotropin releasing hormone (GnRH) antagonists--a new provocation in gynecology].
Vladimirov Ia
Akush Ginekol (Sofiia); 2002; 41(3):36-42. PubMed ID: 12145978
[TBL] [Abstract][Full Text] [Related]
33. GnRH agonists and uterine leiomyomas.
Broekmans FJ
Hum Reprod; 1996 Nov; 11 Suppl 3():3-25. PubMed ID: 9147098
[TBL] [Abstract][Full Text] [Related]
34. Gonadotropin releasing hormone (GnRH) agonist therapy for reduction of leiomyoma volume.
Murphy NJ; Wallace DL
Gynecol Oncol; 1993 May; 49(2):266-7. PubMed ID: 8504999
[TBL] [Abstract][Full Text] [Related]
35. Will GnRH antagonists assist in the treatment of benign gynaecological diseases?
Felberbaum RE; Küpker W; Diedrich K
Reprod Biomed Online; 2002; 5 Suppl 1():68-72. PubMed ID: 12537785
[TBL] [Abstract][Full Text] [Related]
36. An evidence-based approach to hormonal therapies for premenopausal women with fibroids.
Lethaby AE; Vollenhoven BJ
Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):307-31. PubMed ID: 17905660
[TBL] [Abstract][Full Text] [Related]
37. GnRH agonist therapy before myomectomy or hysterectomy.
Gutmann JN; Corson SL
J Minim Invasive Gynecol; 2005; 12(6):529-37; quiz 528, 538-9. PubMed ID: 16337584
[No Abstract] [Full Text] [Related]
38. Morphometric and electron-microscopic analyses of the effects of gonadotropin-releasing hormone agonists on uterine leiomyomas.
Kalir T; Goldstein M; Dottino P; Brodman M; Gordon R; Deligdisch L; Wu H; Gil J
Arch Pathol Lab Med; 1998 May; 122(5):442-6. PubMed ID: 9593346
[TBL] [Abstract][Full Text] [Related]
39. Treatment of uterine fibroids: current findings with gonadotropin-releasing hormone agonists.
Adamson GD
Am J Obstet Gynecol; 1992 Feb; 166(2):746-51. PubMed ID: 1531577
[TBL] [Abstract][Full Text] [Related]
40. Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone.
Engel JB; Schally AV
Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):157-67. PubMed ID: 17237842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
